Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.
about
Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patientsDose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit allPharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactamsAntiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theNevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicinQuantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience.Clinical pharmacokinetics of antiretroviral drugs in older persons.Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.Management of individuals requiring antiretroviral therapy and TB treatment.Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.Population pharmacokinetic analysis of a nevirapine-based HIV-1 prevention of mother-to-child transmission program in Uganda to assess the impact of different dosing regimens for newborns.Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.
P2860
Q24602072-7B3D33D6-89A3-4FDA-8FA3-32C987BF7D48Q24609011-2EBBE28C-549D-443D-A52E-B439F930D27EQ24631021-439789A8-8886-4598-B3F6-73EBE61E0187Q33839294-0A494C3A-C2F2-4016-8966-3EE03F9B45EDQ34149022-958F83A3-646C-4221-BA92-BFEA8FF08706Q34212799-514E320A-30C2-4F42-86F4-896964F8DCE2Q34405883-FAE907EF-3814-4669-9AC4-A1676E2DB7EBQ35598505-62CF6802-2F10-43AC-B80F-82F8D4195656Q36276839-C52A88D6-5D4F-45DA-ACBB-F7535B201831Q36905884-AC5A3165-92C9-4296-B336-6090541B07DDQ37509532-2A3475B6-BB61-4DE3-8417-B68E46F265B5Q37666456-733C87E9-C6AB-4DC8-ABEF-BC02B1571480Q38207924-705CB337-F2EF-4E7C-BB98-109ADAABA5A7Q38720418-BC3C703A-C30A-4A28-9696-906F40A73757Q38865904-2F367286-2BE6-4C4A-BD56-9096F9F152B1Q40736787-8441497F-8761-4349-87E4-3411DEAA0BED
P2860
Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Population pharmacokinetics of ...... fected South African patients.
@ast
Population pharmacokinetics of ...... fected South African patients.
@en
type
label
Population pharmacokinetics of ...... fected South African patients.
@ast
Population pharmacokinetics of ...... fected South African patients.
@en
prefLabel
Population pharmacokinetics of ...... fected South African patients.
@ast
Population pharmacokinetics of ...... fected South African patients.
@en
P2093
P2860
P50
P921
P1476
Population pharmacokinetics of ...... nfected South African patients
@en
P2093
Britt Jansson
Doaa Elsherbiny
Peter Smith
P2860
P2888
P356
10.1007/S00228-008-0481-Y
P577
2008-08-27T00:00:00Z
P5875
P6179
1014987844